ARCOSA INC (ACA) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:ACA • US0396531008

126.56 USD
+1.82 (+1.46%)
At close: Feb 9, 2026
126.56 USD
0 (0%)
After Hours: 2/9/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, ACA scores 5 out of 10 in our fundamental rating. ACA was compared to 55 industry peers in the Construction & Engineering industry. Both the profitability and the financial health of ACA get a neutral evaluation. Nothing too spectacular is happening here. ACA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year ACA was profitable.
  • In the past year ACA had a positive cash flow from operations.
  • In the past 5 years ACA has always been profitable.
  • ACA had a positive operating cash flow in each of the past 5 years.
ACA Yearly Net Income VS EBIT VS OCF VS FCFACA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

  • ACA's Return On Assets of 2.94% is in line compared to the rest of the industry. ACA outperforms 47.27% of its industry peers.
  • With a Return On Equity value of 5.75%, ACA perfoms like the industry average, outperforming 41.82% of the companies in the same industry.
  • ACA has a Return On Invested Capital (4.99%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACA is significantly below the industry average of 15.84%.
  • The last Return On Invested Capital (4.99%) for ACA is above the 3 year average (3.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROIC 4.99%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ACA Yearly ROA, ROE, ROICACA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.25%, ACA is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
  • ACA's Profit Margin has declined in the last couple of years.
  • ACA has a better Operating Margin (10.27%) than 72.73% of its industry peers.
  • ACA's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 21.61%, ACA is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACA has remained more or less at the same level.
Industry RankSector Rank
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
ACA Yearly Profit, Operating, Gross MarginsACA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACA is destroying value.
  • ACA has more shares outstanding than it did 1 year ago.
  • ACA has more shares outstanding than it did 5 years ago.
  • ACA has a worse debt/assets ratio than last year.
ACA Yearly Shares OutstandingACA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ACA Yearly Total Debt VS Total AssetsACA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.65 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.65, ACA perfoms like the industry average, outperforming 49.09% of the companies in the same industry.
  • ACA has a debt to FCF ratio of 5.03. This is a neutral value as ACA would need 5.03 years to pay back of all of its debts.
  • ACA has a Debt to FCF ratio of 5.03. This is in the better half of the industry: ACA outperforms 63.64% of its industry peers.
  • ACA has a Debt/Equity ratio of 0.61. This is a neutral value indicating ACA is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.61, ACA is in line with its industry, outperforming 58.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Altman-Z 2.65
ROIC/WACC0.52
WACC9.54%
ACA Yearly LT Debt VS Equity VS FCFACA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

  • ACA has a Current Ratio of 2.02. This indicates that ACA is financially healthy and has no problem in meeting its short term obligations.
  • ACA's Current ratio of 2.02 is amongst the best of the industry. ACA outperforms 87.27% of its industry peers.
  • A Quick Ratio of 1.30 indicates that ACA should not have too much problems paying its short term obligations.
  • ACA's Quick ratio of 1.30 is in line compared to the rest of the industry. ACA outperforms 58.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.3
ACA Yearly Current Assets VS Current LiabilitesACA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 17.03% over the past year.
  • ACA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.16% yearly.
  • ACA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.96%.
  • Measured over the past years, ACA shows a quite strong growth in Revenue. The Revenue has been growing by 8.15% on average per year.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%

3.2 Future

  • ACA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.76% yearly.
  • Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 7.15% on average per year.
EPS Next Y41.62%
EPS Next 2Y26.58%
EPS Next 3Y21.76%
EPS Next 5YN/A
Revenue Next Year10.81%
Revenue Next 2Y8.17%
Revenue Next 3Y7.15%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ACA Yearly Revenue VS EstimatesACA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ACA Yearly EPS VS EstimatesACA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • ACA is valuated quite expensively with a Price/Earnings ratio of 33.48.
  • Compared to the rest of the industry, the Price/Earnings ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 63.64% of the companies listed in the same industry.
  • ACA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
  • With a Price/Forward Earnings ratio of 26.24, ACA can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, ACA is valued a bit cheaper than 74.55% of the companies in the same industry.
  • ACA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.48
Fwd PE 26.24
ACA Price Earnings VS Forward Price EarningsACA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 81.82% of the companies in the same industry are more expensive than ACA, based on the Enterprise Value to EBITDA ratio.
  • 81.82% of the companies in the same industry are more expensive than ACA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.73
EV/EBITDA 14.64
ACA Per share dataACA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ACA's earnings are expected to grow with 21.76% in the coming years.
PEG (NY)0.8
PEG (5Y)6.48
EPS Next 2Y26.58%
EPS Next 3Y21.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.17%, ACA is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.14, ACA pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.17, ACA pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.17%

5.2 History

  • The dividend of ACA decreases each year by -0.48%.
  • ACA has been paying a dividend for over 5 years, so it has already some track record.
  • As ACA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
ACA Yearly Dividends per shareACA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 6.66% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP6.66%
EPS Next 2Y26.58%
EPS Next 3Y21.76%
ACA Yearly Income VS Free CF VS DividendACA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ACA Dividend Payout.ACA Dividend Payout, showing the Payout Ratio.ACA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ARCOSA INC

NYSE:ACA (2/9/2026, 8:04:00 PM)

After market: 126.56 0 (0%)

126.56

+1.82 (+1.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)10-30
Earnings (Next)02-26
Inst Owners94.81%
Inst Owner Change-2.77%
Ins Owners1.8%
Ins Owner Change-1.18%
Market Cap6.21B
Revenue(TTM)2.83B
Net Income(TTM)148.60M
Analysts86
Price Target126.28 (-0.22%)
Short Float %1.85%
Short Ratio4.11
Dividend
Industry RankSector Rank
Dividend Yield 0.17%
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date01-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)3.34%
PT rev (3m)6.72%
EPS NQ rev (1m)-0.56%
EPS NQ rev (3m)1.71%
EPS NY rev (1m)0.29%
EPS NY rev (3m)4.09%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE 33.48
Fwd PE 26.24
P/S 2.19
P/FCF 19.73
P/OCF 13.23
P/B 2.4
P/tB 6.76
EV/EBITDA 14.64
EPS(TTM)3.78
EY2.99%
EPS(NY)4.82
Fwd EY3.81%
FCF(TTM)6.41
FCFY5.07%
OCF(TTM)9.57
OCFY7.56%
SpS57.76
BVpS52.7
TBVpS18.72
PEG (NY)0.8
PEG (5Y)6.48
Graham Number66.95
Profitability
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROCE 6.5%
ROIC 4.99%
ROICexc 5.24%
ROICexgc 8.62%
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
FCFM 11.11%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Debt/EBITDA 3.04
Cap/Depr 68.36%
Cap/Sales 5.46%
Interest Coverage 250
Cash Conversion 90.74%
Profit Quality 211.71%
Current Ratio 2.02
Quick Ratio 1.3
Altman-Z 2.65
F-Score5
WACC9.54%
ROIC/WACC0.52
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y41.62%
EPS Next 2Y26.58%
EPS Next 3Y21.76%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.81%
Revenue Next 2Y8.17%
Revenue Next 3Y7.15%
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year135.94%
EBIT Next 3Y39.06%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%

ARCOSA INC / ACA FAQ

Can you provide the ChartMill fundamental rating for ARCOSA INC?

ChartMill assigns a fundamental rating of 5 / 10 to ACA.


Can you provide the valuation status for ARCOSA INC?

ChartMill assigns a valuation rating of 5 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.


How profitable is ARCOSA INC (ACA) stock?

ARCOSA INC (ACA) has a profitability rating of 5 / 10.


What is the valuation of ARCOSA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 33.48 and the Price/Book (PB) ratio is 2.4.


How financially healthy is ARCOSA INC?

The financial health rating of ARCOSA INC (ACA) is 5 / 10.